These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17067963)

  • 1. Action of nucleosides and nucleotides at 7 transmembrane-spanning receptors.
    Jacobson KA; Costanzi S; Kim SK; Roh E; Joshi BV; Tchilibon S; Duong HT; Gao ZG
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(12):1425-36. PubMed ID: 17067963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.
    Costanzi S; Mamedova L; Gao ZG; Jacobson KA
    J Med Chem; 2004 Oct; 47(22):5393-404. PubMed ID: 15481977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of ribose ring pucker of signaling nucleosides and nucleotides.
    Salmaso V; Jacobson KA
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):322-341. PubMed ID: 31460850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of A
    Jacobson KA; Kim HS; Ravi G; Kim SK; Lee K; Chen A; Chen W; Kim SG; Barak D; Liang BT; Gao ZG
    Drug Dev Res; 2003 Apr; 58(4):330-339. PubMed ID: 35799977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.
    Gao ZG; Duong HT; Sonina T; Kim SK; Van Rompaey P; Van Calenbergh S; Mamedova L; Kim HO; Kim MJ; Kim AY; Liang BT; Jeong LS; Jacobson KA
    J Med Chem; 2006 May; 49(9):2689-702. PubMed ID: 16640329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists.
    Kim SK; Gao ZG; Van Rompaey P; Gross AS; Chen A; Van Calenbergh S; Jacobson KA
    J Med Chem; 2003 Nov; 46(23):4847-59. PubMed ID: 14584936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structurally related nucleotides as selective agonists and antagonists at P2Y1 receptors.
    Jacobson KA; Moro S; Hoffmann C; Kim YC; Kim HS; Ravi RG; Harden TK; Boyer JL
    Farmaco; 2001; 56(1-2):71-5. PubMed ID: 11347970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings.
    Ravi G; Lee K; Ji X; Kim HS; Soltysiak KA; Marquez VE; Jacobson KA
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2295-300. PubMed ID: 11527718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor.
    Houston D; Costanzi S; Jacobson KA; Harden TK
    Comb Chem High Throughput Screen; 2008 Jul; 11(6):410-9. PubMed ID: 18673269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of ethyl (1S,2R,3S,4S,5S)-2,3-O-(isopropylidene)-4-hydroxy-bicyclo[3.1.0]hexane-carboxylate from L-ribose: a versatile chiral synthon for preparation of adenosine and P2 receptor ligands.
    Joshi BV; Melman A; Mackman RL; Jacobson KA
    Nucleosides Nucleotides Nucleic Acids; 2008 Mar; 27(3):279-91. PubMed ID: 18260011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine receptors: GPCR structure and agonist design.
    Jacobson KA; Kim SK; Costanzi S; Gao ZG
    Mol Interv; 2004 Dec; 4(6):337-47. PubMed ID: 15616163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular recognition at adenine nucleotide (P2) receptors in platelets.
    Jacobson KA; Mamedova L; Joshi BV; Besada P; Costanzi S
    Semin Thromb Hemost; 2005 Apr; 31(2):205-16. PubMed ID: 15852224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling.
    Ivanov AA; Costanzi S; Jacobson KA
    J Comput Aided Mol Des; 2006; 20(7-8):417-26. PubMed ID: 17016747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists.
    Jacobson KA; Ohno M; Duong HT; Kim SK; Tchilibon S; Cesnek M; Holý A; Gao ZG
    Chem Biol; 2005 Feb; 12(2):237-47. PubMed ID: 15734651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine derivatives as ligands for A3 adenosine receptors.
    Joshi BV; Jacobson KA
    Curr Top Med Chem; 2005; 5(13):1275-95. PubMed ID: 16305531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.
    Trujillo K; Paoletta S; Kiselev E; Jacobson KA
    Bioorg Med Chem; 2015 Jul; 23(14):4056-64. PubMed ID: 25868749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the P2Y purinoceptor using rhodopsin as template.
    Van Rhee AM; Fischer B; Van Galen PJ; Jacobson KA
    Drug Des Discov; 1995 Nov; 13(2):133-54. PubMed ID: 8872457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular recognition in purinergic receptors. 1. A comprehensive computational study of the h-P2Y1-receptor.
    Major DT; Fischer B
    J Med Chem; 2004 Aug; 47(18):4391-404. PubMed ID: 15317452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.